The world of myeloproliferative neoplasms (MPNs) has witnessed a surge in scientific breakthroughs. From detecting genetic drivers as early as in the fetus to the unprecedented pace of

We celebrate two members of our Board of Directors recently named MPN Heroes during the Annual Meeting of the American Society of Hematology (ASH). Dr.

Each year at the Annual Meeting of The American Society of Hematology (ASH), there are more MPN research and clinical trial reports. This year, some

Thrive Award Spotlight : Idoroenyi Amanam, MD Using our own immune system to treat cancers has become a reality for many solid and blood cancers.

An MPNRF Patient Impact Council recently launched to actively advocate for the patient voice and perspective in all aspects of our work to promote research

Thrive Award Spotlight : Iannis Aifantis, PhD “Our work has previously focused on other types of blood cancer, including myeloid and lymphoid leukemias,” says Iannis